Evaluation of SNDX-5613 in Participants With Colorectal Cancer and Other Solid Tumors
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
This study will evaluate the safety, tolerability, pharmacokinetics (PK), and anti-tumor activity of SNDX-5613 in participants with colorectal cancer (CRC) or other solid tumors who have failed at least 1 prior line of therapy.
创建时间：
2023-04-15
